메뉴 건너뛰기




Volumn 58, Issue SUPPL. 2, 1999, Pages 231-232

Metabolism and excretion of moxifloxacin

(1)  Stass, H a  


Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; MOXIFLOXACIN;

EID: 0032729634     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00071     Document Type: Conference Paper
Times cited : (15)

References (5)
  • 2
    • 0031582884 scopus 로고    scopus 로고
    • Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing
    • Stass H, Dalhoff A. Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing. J Chromatogr 1997; 702: 163-74
    • (1997) J Chromatogr , vol.702 , pp. 163-174
    • Stass, H.1    Dalhoff, A.2
  • 3
    • 0031903272 scopus 로고    scopus 로고
    • Pharmacokinetics, safety and tolerability of ascending single doses of moxifloxacin, a new 8-methoxyquinolone, administered to healthy subjects
    • Stass H, Dalhoff A, Kubitza D, et al. Pharmacokinetics, safety and tolerability of ascending single doses of moxifloxacin, a new 8-methoxyquinolone, administered to healthy subjects. Antimicrob Agents Chemother 1998; 42 (8): 2060-5
    • (1998) Antimicrob Agents Chemother , vol.42 , Issue.8 , pp. 2060-2065
    • Stass, H.1    Dalhoff, A.2    Kubitza, D.3
  • 4
    • 0345723644 scopus 로고    scopus 로고
    • Crossover study to assess the absolute bio availability and absorption characteristics of BAY 12-8039
    • May 15: Boston. Washington DC: American Society for Microbiology
    • Stass H, Kubitza D. Stass H, Kubitza D. Crossover study to assess the absolute bio availability and absorption characteristics of BAY 12-8039 [abstract no. 59.005]. Proceedings of the 8th International Congress on Infectious Diseases (ICID); 1997 May 15: Boston. Washington DC: American Society for Microbiology, 1998: 197
    • (1997) Proceedings of the 8th International Congress on Infectious Diseases (ICID) , pp. 197
    • Stass, H.1    Kubitza, D.2    Stass, H.3    Kubitza, D.4
  • 5
    • 0344860724 scopus 로고    scopus 로고
    • Mass balance and excretion patterns for moxifloxacin in man following single 400mg oral and intravenous doses
    • May 15: Boston. Washington DC: American Society for Microbiology
    • Stass H, Delesen H, Kubitza D. Mass balance and excretion patterns for moxifloxacin in man following single 400mg oral and intravenous doses [abstract no. 59.004]. Proceedings of the 8th International Congress on Infectious Diseases (ICID); 1997 May 15: Boston. Washington DC: American Society for Microbiology, 1998: 197
    • (1997) Proceedings of the 8th International Congress on Infectious Diseases (ICID) , pp. 197
    • Stass, H.1    Delesen, H.2    Kubitza, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.